CMS Open Payments Reporting Solution

Enhanced Efficiency and Precision: Introducing CMS Open Payments Reporting Solution v3.10

qordata, a leading provider of AI-Powered Data-Driven Compliance Platforms for life sciences companies, is pleased to announce the release of version 3.10 of our upgraded CMS Open Payments Reporting Solution.

This latest update introduces significant enhancements designed to streamline and refine reporting processes, thereby assuring complete, accurate, and timely submission of Federal and State spend reports to the CMS.

Key Enhancements Made to CMS Open Payments Reporting Solution v3.10

Upgraded Pre-Submission Dashboard

The new version merges the “Spend by Drug” and “Spend by Device” dashboards into a consolidated “Spend by Product” dashboard, accessible under the “Track” menu. The consolidation simplifies navigation and provides a comprehensive view of product-related expenditures.

Product Overview Tab Updates
  • Renamed Tab: The “Drug/Device Overview” tab is now the “Product Overview” tab.
  • Enhanced Data Display: Displays data for all products and transactions, including those without an associated product.
Interface Changes:
  • The ‘Drug/Device’ column renamed to ‘Product Name’; shows all product names or “No Product Discussed” for transactions without a product.
  • New “Product Type” Filter: Users can now filter by Drug, Device, Biological, Medical Supply, and No Product Discussed.
  • Improved Reset Button: The reset button now affects all filters, enhancing usability and efficiency.
Spend Transaction Details Tab Updates
  • Merged Columns: The “Drug” and “Device” columns have been combined into a single “Product Name” column.
  • New “Product Type” Column: Displays all product types, including “No Product Discussed.”
  • Integrated Filters: Filters applied in the Product Overview tab are also reflected in the Spend Transaction Details tab, ensuring consistency and ease of use.

Impact of CMS Open Payments Reporting Solution v3.10

The release of CMS Open Payments Reporting Solution v3.10 is designed to have a positive impact on the operational efficiency of life sciences organizations.

By consolidating the “Spend by Drug” and “Spend by Device” dashboards, users can now obtain a holistic view of their expenditures, significantly reducing the time spent navigating between multiple interfaces.

This efficiency not only enhances user experience but also enables quicker decision-making processes, essential in a highly regulated environment. Improved reporting accuracy minimizes the potential for compliance errors and mitigates risks associated with CMS Open Payments Reporting.

For more information, visit qordata.com/cms-open-payments-reporting-solution/ or contact us at [email protected] or (609) 375-0010.